PUBLICATIONS

ZORA Publication List

Publications

ZORA Publication List

Publications

ZORA Publication List

Publications

• 2014

  • Journal Article

    • Paul, J., Yévenes, G. E., Benke, D., Di Lio, A., Ralvenius, W. T., Witschi, R., Scheurer, L., Cook, J. M., Rudolph, U., Fritschy, J.-M., & Zeilhofer, H. U. (2014). Antihyperalgesia by α2-GABAA receptors occurs via a genuine spinal action and does not involve supraspinal sites Neuropsychopharmacology, 39, 477–487. https://doi.org/10.1038/npp.2013.221

• 2013

  • Journal Article

    • Benke, D. (2013). GABAB receptor trafficking and interacting proteins: Targets for the development of highly specific therapeutic strategies to treat neurological disorders? Biochemical Pharmacology, 86, 1525–1530. https://doi.org/10.1016/j.bcp.2013.09.016
    • Zemoura, K., Schenkel, M., Acuña, M. A., Yévenes, G. E., Zeilhofer, H. U., & Benke, D. (2013). Endoplasmic reticulum-associated degradation controls cell surface expression of γ-aminobutyric acid, type b receptors Journal of Biological Chemistry, 288, 34897–34905. https://doi.org/10.1074/jbc.M113.514745

• 2012

  • Journal Article

    • Benke, D., & Zeilhofer, H. U. (2012). Divorce of obligatory partners in pain: disruption of GABA(B) receptor heterodimers in neuralgia The EMBO Journal, 31, 3234–3236. https://doi.org/10.1038/emboj.2012.174
    • Benke, D., Zemoura, K., & Maier, P. J. (2012). Modulation of cell surface GABA(B) receptors by desensitization, trafficking and regulated degradation World Journal of Biological Chemistry, 3, 61–72. https://doi.org/10.4331/wjbc.v3.i4.61
    • Zeilhofer, H. U., Benke, D., & Yévenes, G. E. (2012). Chronic pain states: Pharmacological strategies to restore diminished inhibitory spinal pain control Annual Review of Pharmacology and Toxicology, 52, 111–133. https://doi.org/10.1146/annurev-pharmtox-010611-134636

• 2011

  • Journal Article

    • Panzanelli, P., Gunn, B. G., Schlatter, M. C., Benke, D., Tyagarajan, S. K., Scheiffele, P., Belelli, D., Lambert, J. J., Rudolph, U., & Fritschy, J. M. (2011). Distinct mechanisms regulate GABAA receptor and gephyrin clustering at perisomatic and axo-axonic synapses on CA1 pyramidal cells Journal of Physiology, 589, 4959–4980. https://doi.org/10.1113/jphysiol.2011.216028
    • Di Lio, A., Benke, D., Besson, M., Desmeules, J., Daali, Y., Wang, Z. J., Edwankar, R., Cook, J. M., & Zeilhofer, H. U. (2011). HZ166, a novel GABA(A) receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain Neuropharmacology, 60, 626–632. https://doi.org/10.1016/j.neuropharm.2010.11.026

• 2010

  • Journal Article

    • Maier, P. J., Marin, I., Grampp, T., Sommer, A., & Benke, D. (2010). Sustained glutamate receptor activation downregulates GABA(B) receptors by shifting the balance from recycling to lysosomal degradation Journal of Biological Chemistry, 285, 35606–35614. https://doi.org/10.1074/jbc.M110.142406
    • Benke, D. (2010). Mechanisms of GABAB receptor exocytosis, endocytosis, and degradation Advances in Pharmacology, 58, 93–111. https://doi.org/10.1016/S1054-3589(10)58004-9

• 2009

  • Journal Article

    • Singer, P., Yee, B. K., Feldon, J., Iwasato, T., Itohara, S., Grampp, T., Prenosil, G., Benke, D., Möhler, H., & Boison, D. (2009). Altered mnemonic functions and resistance to N-METHYL-d-Aspartate receptor antagonism by forebrain conditional knockout of glycine transporter 1 Neuroscience, 161, 635–654. https://doi.org/10.1016/j.neuroscience.2009.03.056
    • Balic, E., Rudolph, U., Fritschy, J. M., Mohler, H., & Benke, D. (2009). The alpha5(H105R) mutation impairs alpha5 selective binding properties by altered positioning of the alpha5 subunit in GABAA receptors containing two distinct types of alpha subunits Journal of Neurochemistry, 110, 244–254. https://doi.org/10.1111/j.1471-4159.2009.06119.x
    • Benke, D., Barberis, A., Kopp, S., Altmann, K. H., Schubiger, M., Vogt, K. E., Rudolph, U., & Möhler, H. (2009). GABA(A) receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts Neuropharmacology, 56, 174–181. https://doi.org/10.1016/j.neuropharm.2008.06.013

  • Habilitation

    • Benke, D. (2009). Molecular architecture, distribution and trafficking of neuronal GABA-B receptors (Habilitation, University of Zurich)

• 2008

  • Journal Article

    • Grampp, T., Notz, V., Broll, I., Fischer, N., & Benke, D. (2008). Constitutive, agonist-accelerated, recycling and lysosomal degradation of GABA(B) receptors in cortical neurons Molecular and Cellular Neurosciences, 39, 628–637. https://doi.org/10.1016/j.mcn.2008.09.004

• 2006

  • Journal Article

    • Yee, B. K., Balic, E., Singer, P., Schwerdel, C., Grampp, T., Gabernet, L., Knuesel, I., Benke, D., Feldon, J., Mohler, H., & Boison, D. (2006). Disruption of glycine transporter 1 restricted to forebrain neurons is associated with a procognitive and antipsychotic phenotypic profile Journal of Neuroscience, 26, 3169–3181. https://doi.org/10.1523/JNEUROSCI.5120-05.2006

• 2004

  • Journal Article

    • Benke, D., Fakitsas, P., Roggenmoser, C., Michel, C., Rudolph, U., & Mohler, H. (2004). Analysis of the presence and abundance of GABAA receptors containing two different types of alpha subunits in murine brain using point-mutated alpha subunits Journal of Biological Chemistry, 279, 43654–43660. https://doi.org/10.1074/jbc.M407154200

• 2000

  • Journal Article

    • Gao, B., Hagenbuch, B., Kullak-Ublick, G. A., Benke, D., Aguzzi, A., & Meier-Abt, P. J. (2000). Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. Journal of Pharmacology and Experimental Therapeutics, 249, 73–79.

Pagination

ZORA Publication List

Publications

ZORA Publication List

Publications